Killer upgrades

The advantages of NK cells first piqued cancer researchers' interest two decades ago, but issues such as the cells' inability to last long in the body hindered development. For those who received NK cells from such optimal cord-blood units, the one-year survival rate was 69%. About 15 year...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nature (London) 2024-05, Vol.629 (8014), p.S4-S6
1. Verfasser:	Keener, Amanda
Format:	Artikel
Sprache:	eng
Schlagworte:	Biotechnology industry Cancer Cancer therapies Cells Clinical trials Cord blood Cytokine storm Genetic engineering Lymphocytes Medical research Oxidative stress Researchers Survival Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!